This page does not exist in your selected language. Your preference was saved and you will be notified once a page can be viewed in your language.
This page is also available in your prefered language.
Switch to self version.
Sensitive and adaptable pharmacological control of CAR T cells through extracellular receptor dimerization
Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors
High-Throughput Flow Cytometric Method for the Simultaneous Measurement of CAR-T Cell Characterization and Cytotoxicity Against Solid Tumor Cell Lines
TGF‐β–responsive CAR‐T cells promote anti‐tumor immune function
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.